Literature DB >> 28474060

[Changes of TGF-β1 expression during orthodontic tooth movement in rats with osteoporosis].

Ming-He Li1, Yang Wang, Nan-Nan Liao, Jin-Yuan Li, Qing Dong.   

Abstract

PURPOSES: To observe the expression and distribution of TGF-β1 in periodontal tissue under intervention of Strontium ranelate and Qianggu capsule during orthodontic tooth movement in rats, and explore the efficacy of the 2 drugs.
METHODS: Seventy male SD rats of 3 months old were selected in the study, and randomly divided into control group, model control group, Strontium ranelate group, Qianggu capsule group, each group had 15 animals. Retinoic acid was given by gavage to animals in the control group, Strontium ranelate group, Qianggu capsule group for 2 weeks, and bone density was detected to determine successful establishment of osteoporosis model. All rats were installed orthodontic device, and were sacrificed at 7 days, 14 days and 21 days, respectively. The tissue blocks of the first maxillary molar and adjacent alveolar bone were taken for H-E staining, immunohistochemical staining and semi-quantitative analysis was used to detect TGF-β1 expression in periodontal tissues. The data were statistically analyzed by SPSS 17.0 software package.
RESULTS: TGF- beta 1 expression was significantly increased in Strontium ranelate group and Qianggu capsule group compared with control group (P<0.05); TGF- beta 1 expression in Strontium ranelate group was significantly stronger than that of Qianggu capsule group (P<0.05).
CONCLUSIONS: Strontium ranelate and Qianggu capsule could enhance the expression of TGF- beta 1 and promote bone metabolism in osteoporosis rats, which is helpful to the movement of healthy teeth; the effect of Strontium ranelate is stronger than Qianggu capsule.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28474060

Source DB:  PubMed          Journal:  Shanghai Kou Qiang Yi Xue        ISSN: 1006-7248


  1 in total

1.  Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis.

Authors:  Ann Yehong Huang; Zhencheng Xiong; Kuankuan Liu; Yanan Chang; Li Shu; Guolan Gao; Chi Zhang
Journal:  Front Pharmacol       Date:  2022-09-23       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.